Biotech Values

[randychub]

Master what happens to

osip survival rate p-value, if like irressa, long term survivors have a mutant egf'r. If you remove that subset of patients from the traveca trial, is the p-value still significant?

If those patients are the only patients treated with traveca, a market that would be shared by irressa, the number of patients taking this drug drops very significantly.

I posted this on the yahoo osip board also. I would appreciate any comments.

Thanks


Randy